S&P 500 7,811.54 +0.59%Nasdaq 27,366.17 +0.64%Dow 51,654.95 +0.83%Russell 2000 2,806.98 +0.46%as of 2026-10-09 close
▚ The MicroCap Herald
Micro-cap and nano-cap intelligence, before the crowd
Market Pulse

Eleven Small-Company Reverse Splits Took Effect Between Sept. 28 and Oct. 8, From 1-for-10 to 5,000-for-1. Under Nasdaq Rule 5810(c)(3)(A)(iv), Each of the Seven Nasdaq Names on the List Has No Cure Period if Its Bid Fails the $1 Test Within a Year.

8-Ks on EDGAR show seven Nasdaq, two NYSE American and two OTC consolidations among the micro- and small-caps we tracked, with two more Nasdaq splits set for Oct. 12; the list is not exhaustive. Vivakor's 1-for-15 follows a 1-for-20 in July, a cumulative 300-to-1 by our arithmetic, above the rule's 250-to-1 two-year threshold.
Illustrative photograph: US banknotes and coins.

Eleven small US-listed or OTC-quoted companies put reverse stock splits into effect between Monday, Sept. 28 and Thursday, Oct. 8, according to their own Form 8-Ks, which we identified through a full-text search of 8-Ks filed Sept. 28 to Oct. 10 for the phrase 'reverse stock split.' Of the eleven detailed here, seven trade on Nasdaq, two on NYSE American and two over the counter. Ratios run from 1-for-10 to 5,000-for-1, and two further Nasdaq consolidations, at Dragonfly Energy and NexGel, are set for Monday, Oct. 12.

The list is ours and is not exhaustive: the search returned 213 documents, and other companies not covered here, among them Granite Point Mortgage Trust (NYSE: GPMT, 1-for-10, effective 5 p.m. Oct. 5), PLAYSTUDIOS (Nasdaq: MYPS, 1-for-10, effective 5 p.m. Sept. 30) and Fractyl Health (Nasdaq: GUTS, 1-for-12, effective 5 p.m. Oct. 2), also consolidated in the window.

The roster, in order of effectiveness, from the filings: Matinas BioPharma (NYSE American: MTNB), 1-for-15, Sept. 28; Cheetah Net Supply Chain Service (Nasdaq: CTNT), 1-for-150 on both share classes, market-effective Sept. 28; OneMedNet (Nasdaq: ONMD), 1-for-10, Sept. 29; TruGolf Holdings (Nasdaq: TRUG), 1-for-10, Sept. 29; SHF Holdings, which calls itself Safe Harbor in its filings (Nasdaq: SHFS), 1-for-12, Sept. 30; Kustom Entertainment (Nasdaq: KUST), 1-for-10, Oct. 1; Transportation and Logistics Systems (OTCID: TLSS), 5,000-for-1, Oct. 2; Vivakor (Nasdaq: VIVK), 1-for-15, Oct. 5; Scienture Holdings (Nasdaq: SCNX), 1-for-25, Oct. 5; Catheter Precision, renamed Flyte Aviation the same morning (NYSE American: VJET), 1-for-10, Oct. 5; and Blue Star Foods (OTC: BSFC), 1-for-1,600, Oct. 8.

The share counts left behind are small. Kustom Entertainment's 8-K states the outstanding count went from 6,506,860 to 650,686, 'subject to adjustment for the rounding up of fractional shares.' Cheetah Net says that after its 1-for-150 it 'has approximately 1,332,087 shares of Class A Common Stock and approximately 1,358 shares of Class B Common Stock issued and outstanding'; the same filing discloses that as of Sept. 25 it had sold 'approximately 196,850,000 shares' pre-split under a $35,280,213.01 at-the-market agreement. Flyte Aviation reports 'approximately 2,101,987 shares' after its split. Vivakor's release projected a reduction 'from approximately 8,981,898 to approximately 598,794'; TruGolf's projected 'approximately 12.44 million shares' becoming 'approximately 1.24 million.'

Two filers said in plain words that the bid-price rule was the reason. Scienture's 8-K: 'The Company effected the Reverse Stock Split to, among other things, regain compliance with The Nasdaq Stock Market LLC's continued listing rules, which require that the minimum bid price of the Company's common stock be at least $1.00 per share.' OneMedNet's: 'The Reverse Stock Split is intended to bring the Company into compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market.' Dragonfly Energy's 8-K for its Oct. 12 split says it 'is intended to increase the closing bid price of the Company's Common Stock above $1.00 per share, and to enable the Company to manage continued compliance with Nasdaq Listing Rule 5550(a)(2).' Kustom, SHF, TruGolf and Cheetah Net gave no reason in the filings we read.

The rule those companies are managing is Nasdaq Listing Rule 5810(c)(3)(A), and its first sentences set the clock: 'A failure to meet the continued listing requirement for minimum bid price shall be determined to exist if the deficiency continues for a period of 30 consecutive business days. Upon such failure, the Company shall be notified promptly and shall have a period of 180 calendar days from such notification to achieve compliance. Compliance can be achieved during any compliance period by meeting the applicable standard for a minimum of 10 consecutive business days during the applicable compliance period, unless Staff exercises its discretion to extend this 10 day period as discussed in Rule 5810(c)(3)(H).'

The second window is conditional, not automatic. Subparagraph (ii) reads: 'If a Company listed on the Capital Market is not deemed in compliance before the expiration of the 180 day compliance period, it will be afforded an additional 180 day compliance period, provided that on the 180th day of the first compliance period it meets the applicable market value of publicly held shares requirement for continued listing and all other applicable standards for initial listing on the Capital Market (except the bid price requirement) based on the Company's most recent public filings and market information and notifies Nasdaq of its intent to cure this deficiency.'

Read literally, each of the seven Nasdaq companies on this list has, by the act of splitting, given up the 180-day clock for the twelve months that follow its split. If any of them records 30 consecutive business days below $1.00 within that year, the text provides for a delisting determination rather than a notice and a cure period; such a determination can be appealed to a Nasdaq Hearings Panel, the route Liminatus Pharma took earlier this year, per its Sept. 29 8-K. The rule does not distinguish a split done to fix a deficiency from one done pre-emptively.

Read literally, each of the seven Nasdaq companies that consolidated in the past two weeks has, by the act of splitting, given up the 180-day clock for the next twelve months. If any of them records 30 consecutive business days below $1.00 before autumn 2027, the text provides for a delisting determination rather than a notice and a cure period; a determination can be appealed to a Hearings Panel, a shorter process. The rule does not distinguish a split done to fix a deficiency from one done pre-emptively.

Subparagraph (iii), 'Low Priced Stocks,' is the other trapdoor: 'a failure to meet the continued listing requirement for minimum bid price shall be determined to exist if a Company's security has a closing bid price of $0.10 or less for ten consecutive business days,' upon which staff 'shall issue a Staff Delisting Determination' and 'the Company shall be ineligible for any compliance period otherwise described in this Rule 5810(c)(3)(A).' That provision pushes companies toward large ratios while prices are still above a dime.

The two OTC consolidations are of a different order and outside Nasdaq's rule. Transportation and Logistics Systems' 5,000-for-1, approved by stockholders Aug. 11, took effect Oct. 2, with split-adjusted trading to begin 'once The Depository Trust Company completes processing of the rounding up of fractional shares at the beneficial owner level,' per the 8-K. Blue Star Foods' 1-for-1,600 was processed by FINRA under Rule 6490 with a market-effective date of Oct. 8; the filing notes that 'FINRA has neither approved nor disapproved the corporate action.' Splits also trigger other terms: TruGolf's Oct. 9 8-K states that 'On September 29, 2026, the Company completed a reverse stock split, and, as such, the conversion price of the Series B preferred stock will be reduced on October 19, 2026 pursuant to such provision' of its Series B certificate of designation.

What is next: Dragonfly Energy's 1-for-8 and NexGel's 1-for-20 become effective at 12:01 a.m. on Oct. 12, Pacific and Eastern time respectively, per their 8-Ks; Our Bond (Nasdaq: OBAI) has approval for a 1-for-20 but had disclosed no effective date as of Oct. 1. Liminatus Pharma (Nasdaq: LIMN), which split 1-for-50 on Aug. 20, said in a Sept. 29 8-K that Nasdaq had found its closing bid above $1.00 'for the 13 consecutive trading days from August 21, 2026 to September 9, 2026' and that 'the matter is now closed' — it, too, now sits inside (iv)'s one-year window. The rulebook page also carries a notice that the SEC has stayed its approval order for Nasdaq rule filing SR-NASDAQ-2026-004; we have not reviewed that filing. None of the 8-Ks say where the stocks closed afterward; whether the splits hold above $1.00 for the 10 consecutive business days the rule requires is a question for the tape in the weeks ahead.

This article is for general information only and is not investment advice. Figures are as reported by the cited sources at time of writing.

Related coverage